NCT04189679View on ClinicalTrials.gov

Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

January 27, 2023

Study Completion Date

January 27, 2023

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

Immune signature in serum associated to the metabolic signature

Immune signature in serum associated to the metabolic signature

GENETIC

Meta-genomic signature of intestinal flora

Meta-genomic signature of intestinal flora

Trial Locations (1)

38700

University Hospital, Grenoble, La Tronche

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT04189679 - Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma | Biotech Hunter | Biotech Hunter